Small Molecule Discovery
Hyperbinding
Unlock drug design for Unresolved protein targets
Unlock drug design for Unresolved protein targets
Employ cutting-edge co-folding AI to predict protein-ligand complex structures and binding scores with high accuracy.
Enable drug design for proteins without PDB structures.
Employ cutting-edge co-folding AI to predict protein-ligand complex structures and binding scores with high accuracy.
Enable drug design for proteins without PDB structures.
See protein and ligand changes in action
See protein and ligand changes in action
Visualize how ligand changes reshape protein structures through co-folding, clarifying their impact on interactions.
Predict structures of protein–protein or protein–nucleic acid complexes with precision.
Visualize how ligand changes reshape protein structures through co-folding, clarifying their impact on interactions.
Predict structures of protein–protein or protein–nucleic acid complexes with precision.
Start with just a protein name
No PDB ID needed. Input the protein name, and HyperLab provides optimal input from our carefully curated database.
HyperLab also provides binding-site residues and impactful cofactors, supported by validated experimental data.
Easily add and edit detailed input information, such as mutations, post-translational modifications, and cofactors.
No PDB ID needed. Input the protein name, and HyperLab provides optimal input from our carefully curated database.
HyperLab also provides binding-site residues and impactful cofactors, supported by validated experimental data.
Easily add and edit detailed input information, such as mutations, post-translational modifications, and cofactors.
Achieve precise structures and scores
Accurate 3D structures lead to more reliable binding scores. Hyper Binding Co-folding delivers both with exceptional precision.
Accurate 3D structures lead to more reliable binding scores. Hyper Binding Co-folding delivers both with exceptional precision.
Small Molecule Discovery
Hyperbinding Co-folding
Small Molecule Discovery
Hyperbinding Co-folding
Ready to revolutionize
Your drug discovery process?
Sign up with your email and start using HyperLab right now
—
AI drug discovery Platform
HITS Inc.
CEO : Woo Youn Kim
Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu, Seoul, Republic of Korea
© HITS Inc. All rights reserved.
Ready to revolutionize
Your drug discovery process?
Sign up with your email and start using HyperLab right now
—
AI drug discovery Platform
Small Molecule Discovery
Publications
HITS Inc.
CEO : Woo Youn Kim
Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu, Seoul, Republic of Korea
© HITS Inc. All rights reserved.
Ready to revolutionize
Your drug discovery process?
Sign up with your email and start using HyperLab right now
HITS Inc.
CEO : Woo Youn Kim
Address : 8F, 28, Teheran-ro 4-gil, Gangnam-gu,
Seoul, Republic of Korea
© HITS Inc. All rights reserved.